Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Soneas Research is a Hungary-based Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO) specializing in small molecule chemistry. The company provides a comprehensive range of services including discovery chemistry, process research and development, and analytical services to the pharmaceutical and fine chemical industries. Soneas operates state-of-the-art laboratories and pilot plant facilities capable of supporting projects from initial lead optimization through to GMP-compliant clinical trial material manufacturing. In 2018, the company was acquired by UPL, a global leader in agricultural solutions, to enhance its research and development capabilities in specialty chemicals and pharmaceutical intermediates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SONEAS Research.